CLASS II Drug recall · Reported 17 Oct 2018 · FDA Enforcement Report

Magnesium Sulfate in Water for Injection recalled by Pfizer

Pfizer is recalling Magnesium Sulfate in Water for Injection (0.325 mEq Mg++/mL) 40 mg/mL Total Single-Dose, distributed nationwide in the US. The recall was initiated on 3 Oct 2018 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot: 87904FW, Exp. 1MAR2020
Quantity recalled94,752 bags

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0015-2019
FDA event ID
81126
Recalling firm
Pfizer, New York, NY
Classification
Class II
Status
Terminated
Recall initiated
3 Oct 2018
FDA classified
11 Oct 2018
Reported
17 Oct 2018
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Packaging Defects

Timeline

3 Oct 2018Recall initiated by company
11 Oct 2018Classified by FDA+8 days
17 Oct 2018Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Correct Labeled Product Mispack: confirmed report involving a single unit of properly labeled Heparin in 0.45% Sodium Chloride for Injection (NDC 0409-7651-03, Lot 87903FW) that was found inside a case of Magnesium Sulfate in Water for Injection.

Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.

Product as listed by the FDA

Magnesium Sulfate in Water for Injection (0.325 mEq Mg++/mL) 40 mg/mL, 20 g Total, 500 mL Single-Dose Container bag, Rx only, Hospira, Inc. Lake Forest, IL 60045 USA, NDC 0409-6729-03.

Where it was distributed

Nationwide in the USA and Puerto Rico

Nationwide Puerto Rico

Questions about this recall

Why was it recalled?

Correct Labeled Product Mispack: confirmed report involving a single unit of properly labeled Heparin in 0.45% Sodium Chloride for Injection (NDC 0409-7651-03, Lot 87903FW) that was found inside a case of Magnesium Sulfate in Water for Injection.

Which lots are affected?

Lot: 87904FW, Exp. 1MAR2020

Where was it sold?

Nationwide in the USA and Puerto Rico

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Pfizer

All 129

Other Magnesium recalls

All 25